Author

P. R

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Biophysics· 1 Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:statistical model· 3 Approach:deep learning· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:mechanistic / dynamical model· 1

Frequent Co-Authors

C. D. Arulanandam· 3 shared A. Das· 1 shared A. Yadav· 1 shared G. Rasiravathanahalli Kaveriyappan· 1 shared K. Mandal· 1 shared M. Gupta· 1 shared R. Das· 1 shared R. K. Govindarajan· 1 shared

Activity by Year

2020-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBioengineering

C. D. Arulanandam

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

In Silico: Mutagenicity and carcinogenicity prediction of Sugar substitutes

C. D. Arulanandam, V. Babu, Y. Soorni, P. R

The paper predicts mutagenicity and carcinogenicity of sugar substitutes using in silico methods and PubChem data.

bioRxiv · Jan 28, 2021 · PreprintBioengineering

Repurposing of an Antifungal Drug against Gastrointestinal Stromal Tumors

C. D. Arulanandam, P. R, G. Rasiravathanahalli Kaveriyappan

This study identifies Itraconazole as a potential PDGFRA inhibitor through virtual screening of FDA-approved drugs for GIST treatment.

bioRxiv · Jan 15, 2021 · PreprintCancer Biology

Raspberry pi: Assessments of emerging organic chemicals by the predictive in silico methods

C. D. Arulanandam, P. R, R. K. Govindarajan

This study assesses the toxicity of plasticizers using in silico tools, finding none are hERG blockers and some are non-skin sensitizers.

bioRxiv · Jan 15, 2021 · PreprintPharmacology & Toxicology

Rational design of protein-specific folding modifiers

A. Das, A. Yadav, M. Gupta, P. R, V. L. Terse, V. Vishvakarma, S. Singh, T. Nandi, K. Mandal, S. Gosavi, R. Das, S. R. K. Ainavarapu, S. Maiti

This paper designs a method to create protein-specific folding modifiers using xenonuclei, showing they can accelerate protein refolding by 33% under specific conditions.

bioRxiv · Apr 28, 2020Biophysics